Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00919412 · ClinicalTrials.gov registry record
Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 32
- Enrollment target
NCT00919412 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 32 participants.
The verdict
NCT00919412 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The goal of this study is to identify a non-invasive predictor or predictors that will increase the clinician's ability to identify patients with preterm labor (PTL) at risk for preterm delivery (PTD). Through these studies we also hope to reveal potential therapeutic targets in the prevention of prevention of preterm births. The study hypothesis is that we can identify non-invasive predictors of PTL at risk for PTD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00919412
The ClinicalTrials.gov registry entry for NCT00919412 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00919412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00919412 about?
NCT00919412 is a clinical study titled "Non Invasive Biomarkers to Identify Subjects at Risk for Preterm Delivery". The goal of this study is to identify a non-invasive predictor or predictors that will increase the clinician's ability to identify patients with preterm labor (PTL) at risk for preterm delivery (PTD). Through these studies we also hope to reveal potential therapeutic targets in the prevention of pr...
What is the current status of trial NCT00919412?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2007-06. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00919412?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.